Comparative investigation of the effect of Ukrain on growth of ascite and solid forms of Ehrlich's carcinoma

Experimental Oncology

Volumn 32, Issue 2, 2010, Pages 107-110

  Susak, Ya M ^b   Skivka, L M ^a   Rudik, M P ^a   Pozur, V V ^a   Liubunya, A V ^a  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Ascite and solid forms of ehrlich's carcinoma; Ukrain

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; NSC 631570; UKRAIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL CYCLE PHASE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SELECTIVITY; EHRLICH ASCITES TUMOR; FEMALE; FLOW CYTOMETRY; IMMUNOMODULATION; INFLAMMATION; LD 50; LIFESPAN; MOUSE; NONHUMAN; PHAGOCYTE; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; CARCINOMA, EHRLICH TUMOR; CELL CYCLE; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; MICE; PHAGOCYTES; PHENANTHRIDINES;

EID: 77954615831     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gansauge F, Ramadani M, Schwarz M, et al. The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. Hepatogas-troenterology 2007; 54: 917-20. (Pubitemid 46903753)
2. Ernst E, Schmidt K. Ukrain - a new cancer cure? A systematic review of randomised clinical trials. BMC Cancer 2005; 5: 69. (Pubitemid 41461062)
3. Lanvers-Kaminsky C, Nolting DM, Köster J, et al. In vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs 2006; 17: 1025-30.
4. Grinevich Y, Shalimov S, Bendyuh G, et al. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice. Drugs Exp Clin Res 2005; 31: 59-70.
5. Mozhenok TP, Beliaeva TN, Leont'eva EA, et al. Effect of alkaloid sanguinarine and a pharmaceutical preparation Ukrain on modulation of vesicular membrane fusion and actin cytoskeleton of macrophages. Tsitologiia 2005; 47: 860-5.
6. Lee YC, Kim SH, Roh SS, et al. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice. J Ethnopharmacol 2007; 112: 40-8.
7. Hruby R. Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats. Drugs Exp Clin Res 2000; 26: 157-61. (Pubitemid 32373340)
8. Uglyanitsa KN, Nefyodov LI, Brzosko V. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application. Drugs Exp Clin Res 2000; 26: 223-30.
9. Glazev AA, Nefedov LI. Changes in amino acid patterns of blood plasma in tumor patients treated with anticancer drug NSC-631570: possible approaches to cancer diagnostics. Biomed Khim 2008; 54: 289-300.
10. Sofiina ZP, Syrkina AB, Goldina A., et al. An experimental evaluation of anticancer drugs in the USSR and USA. M: Medytsina, 1980. 292 p (In Russian).
11. Kleeb SR, dos S Rizzo M, Dagli ML, et al. Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: a possible mechanism for its antitumoral effect. Int J Immunopharmacol 1999; 21: 575-80.
12. Johansson M, Persson JL. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med Chem 2008; 8: 723-31.
13. Habermehl D, Kammerer B, Handrick R, et al. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alcaloids and mediated via a mitochondrial death pathway. BMC Cancer 2006; 6: 14.
14. Kazmin SD, Todor IN. The effect of antitumor drug Ukrain on malignant proliferating cells being at different stages of cell cycle. Int J Biol Environ 2000; 28: 57-64.